Haemonetics (HAE) Enterprise Value Growth (1y) (2010 - 2026)
Haemonetics (HAE) Enterprise Value Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Haemonetics | 3.79 Bn | 3.54 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 19.99% |
| Dec 27, 2025 | -13.25% |
| Sep 27, 2025 | 0.95% |
| Jun 28, 2025 | 14.96% |
| Mar 29, 2025 | -71.57% |
| Dec 28, 2024 | -65.40% |
| Sep 28, 2024 | 14.74% |
| Jun 29, 2024 | -20.55% |
| Mar 30, 2024 | 37.15% |
| Dec 30, 2023 | 13.40% |
| Sep 30, 2023 | -45.52% |
| Jul 1, 2023 | -32.92% |
| Apr 1, 2023 | -9.62% |
| Dec 31, 2022 | 5.44% |
| Oct 1, 2022 | -25.35% |
| Jul 2, 2022 | -23.92% |
| Apr 2, 2022 | -34.94% |
| Jan 1, 2022 | -25.33% |
| Oct 2, 2021 | 31.07% |
| Jul 3, 2021 | 37.09% |